<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many <z:e sem="disease" ids="C1333990" disease_type="Neoplastic Process" abbrv="">hereditary nonpolyposis colorectal cancers</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) cannot be explained by <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Other high penetrance genetic risk factors are likely to play a role in these mismatch repair (MMR)-proficient <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> families </plain></SENT>
<SENT sid="2" pm="."><plain>Because genomic profiles of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tend to vary with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> susceptibility syndromes, our aim is to analyze the genomic profile of MMR-proficient familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> to obtain insight into the biological basis of MMR-proficient familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We studied 30 MMR-proficient familial colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp>, from 15 families, for genomic aberrations, including gains, physical losses, and copy-neutral loss of heterozygosity LOH (cnLOH) using SNP array comparative genomic hybridization </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, we performed <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> analysis for KRAS, BRAF, PIK3CA and GNAS </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of 20q gain (77%) is remarkably increased when compared with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, suggesting that 20q gain is involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> of familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>There is also a significant increase in the frequency of cnLOH and, as a consequence, a reduced frequency of physical loss compared with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The most frequent aberrations observed included gains of 7p, 7q, 8q, 13q, 20p and 20q as well as physical losses of 17p, 18p and 18q </plain></SENT>
<SENT sid="8" pm="."><plain>Most of these changes are also observed in <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Mutations in KRAS were identified in 37% of the MMR-proficient <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, and mutations in BRAF were identified in 16% </plain></SENT>
<SENT sid="10" pm="."><plain>No mutations were identified in PIK3CA or chromosome 20 candidate gene GNAS </plain></SENT>
<SENT sid="11" pm="."><plain>We show that the patterns of <z:mp ids='MP_0008866'>chromosomal instability</z:mp> of MMR-proficient familial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> are clearly distinct from those from <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Both the increased gain on chromosome 20 and the increased levels of cnLOH suggest the presence of yet undiscovered germline defects that can, in part, underlie the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in these families </plain></SENT>
</text></document>